This article is part of “Innovations In: Sickle Cell Disease,” an editorially independent special report that was produced with financial support from Vertex Pharmaceuticals. Sickle cell disease was ...
Sickle cell disease affects between 12,500 and 15,000 people in England. Ezume Images/ Shutterstock A drug that can treat severe sickle cell disease has recently been given approval by the National ...
Investor's Business Daily on MSN
Agios rallies on a surprise FDA move in sickle cell, pulling rival Fulcrum higher
Agios Pharmaceuticals stock jumped Tuesday after the company said it would seek an accelerated approval for its sickle cell treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results